Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Acute Disease

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Acute Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argentino, C; Bozzao, L; Di Piero, V; Fieschi, C; Giubilei, F; Lenzi, GL; Pantano, P; Rasura, M1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Acute Disease

ArticleYear
[SPECT study of acute cerebral ischemia. Preliminary results of the Unità de Roma].
    Minerva medica, 1988, Volume: 79, Issue:8

    Topics: Acute Disease; Aged; Brain Ischemia; Female; Humans; Iodobenzenes; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Oximes; Rome; Tomography, Emission-Computed

1988